HAEM5:EBV-positive diffuse large B-cell lymphoma: Difference between revisions
| [pending revision] | [pending revision] |
Fnu.Monika (talk | contribs) |
Fnu.Monika (talk | contribs) |
||
| Line 167: | Line 167: | ||
| | | | ||
| | | | ||
| | |Impaired ''TNFRSF21/DR6'' function has been associated with increased cell proliferation and reduced apoptosis in B- and T-cell malignancies, including EBV-associated AITL<ref>{{Cite journal|last=Wang|first=Ming|last2=Zhang|first2=Shaowei|last3=Chuang|first3=Shih-Sung|last4=Ashton-Key|first4=Margaret|last5=Ochoa|first5=Eguzkine|last6=Bolli|first6=Niccolo|last7=Vassiliou|first7=George|last8=Gao|first8=Zifen|last9=Du|first9=Ming-Qing|date=2017-03-14|title=Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling|url=https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.14846|journal=Oncotarget|language=en|volume=8|issue=11|pages=17763–17770|doi=10.18632/oncotarget.14846|issn=1949-2553|pmc=5392284|pmid=28148900}}</ref> | ||
|- | |- | ||
|''CSNK2B''<ref name=":2" /> | |''CSNK2B''<ref name=":2" /> | ||